Skip to main content
Fig. 5 | BMC Medical Research Methodology

Fig. 5

From: Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer

Fig. 5

The impact of the percentage of patients who should be referred to a different hospital on the diagnostic pathway duration is expressed in days. The assumption underlying referrals is that all patients for whom no biomarker was identified in their current hospital are patients who should be referred if there is more elaborate biomarker testing available elsewhere. The length of each violin symbolizes the uncertainty in the estimate of the mean diagnostic pathway duration. The boxplots show the median and interquartile ranges

Back to article page